SIGA Technologies, Inc.
NASDAQ•SIGA
CEO: Dr. Dennis E. Hruby Ph.D.
板块: Healthcare
行业: Drug Manufacturers - Specialty & Generic
上市日期: 1997-09-10
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
联系方式
市值
$309.85M
市盈率 (TTM)
15.3
11.2
股息率
13.9%
52周最高
$9.62
52周最低
$4.10
52周范围
排名30Top 19.5%
5.1
F-Score
改良版 Piotroski 分析
基于 10 年期基本面
一般 • 5.1 / 9 分
评分区间 (0-9)
8-9: 价值优异
6-7: 基本面强劲
4-5: 整体稳健
0-3: 表现疲弱
数据范围: 2016-2025
深度研究
财务数据
电话会议
财务报告
新闻
利润表
资产负债表
现金流量表
财务比率
变化率
利润表 | 过去12个月 |
|---|
无数据